SAKK 19/17: safety analysis of first-line durvalumab in patients with PD-L1 positive, advanced nonsmall cell lung cancer and a performance status of 2
Titel:
SAKK 19/17: safety analysis of first-line durvalumab in patients with PD-L1 positive, advanced nonsmall cell lung cancer and a performance status of 2
Auteur:
Mark, Michael Froesch, Patrizia Eboulet, Eric Innocents Addeo, Alfredo Pless, Miklos Rothschild, Sacha I. Janthur, Wolf-Dieter Burmeister, Henning Friedlaender, Alex Schneider, Martina Metaxas, Yannis Joerger, Markus Wannesson, Luciano Schwitter, Michael Baudoux, Nathalie Weindler, Susanne Biaggi-Rudolf, Christine Früh, Martin ,